Equasym XL 40 mg modified-release capsules, hard
- Licence status
- Active substances
- Methylphenidate hydrochloride
- Dosage Form
- Modified-release capsule, hard
- Licence number
- PA23211/001/004
- Licence holder
- Takeda Pharmaceuticals International AG Ireland Branch
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- N06BA Centrally acting sympathomimetics, N06BA04 methylphenidate
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, 4.2). This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 08/02/2013